Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations

被引：0
|
作者：
Botesteanu, Dana-Adriana
Levy, Doron
Lee, Jung-Min
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2709
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Germline mutations in BRCA1 and BRCA2 in Polish families predisposed to breast and ovary cancers
    Grzybowska, E
    Jasinska, A
    Kozlowski, P
    Zientek, H
    Krzyzosiak, W
    Utracka-Hutka, B
    Wloch, J
    Rogozinsca-Szczepka, J
    DISEASE MARKERS, 1999, 15 (1-3) : 103 - 103
  • [42] High Frequency of BRCA1 and BRCA2 Germline Mutations in a Series of Resected Pancreatic Adenocarcinoma and Other Preneoplastic Lesions Suggests an Association With BRCA1 and BRCA2 Mutations
    Lucas, Aimee L.
    Mitchel, Elana B.
    Hwang, Caroline
    Kumar, Sheila
    Deng, Liyong
    Shakya, Reena
    Ludwig, Thomas
    Chabot, John A.
    Chung, Wendy
    Frucht, Hatold
    GASTROENTEROLOGY, 2011, 140 (05) : S355 - S355
  • [43] A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia
    Andrey Kechin
    Ulyana Boyarskikh
    Alexey Barinov
    Alexander Tanas
    Svetlana Kazakova
    Anastasia Zhevlova
    Evgeniy Khrapov
    Sergey Subbotin
    Olga Mishukova
    Tatiana Kekeeva
    Irina Demidova
    Maxim Filipenko
    Breast Cancer Research and Treatment, 2023, 197 : 387 - 395
  • [44] A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia
    Kechin, Andrey
    Boyarskikh, Ulyana
    Barinov, Alexey
    Tanas, Alexander
    Kazakova, Svetlana
    Zhevlova, Anastasia
    Khrapov, Evgeniy
    Subbotin, Sergey
    Mishukova, Olga
    Kekeeva, Tatiana
    Demidova, Irina
    Filipenko, Maxim
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (02) : 387 - 395
  • [45] Pathology of ovarian cancers in BRCA1 and BRCA2 carriers
    Lakhani, SR
    Manek, S
    Penault-Llorca, F
    Flanagan, A
    Arnout, L
    Merrett, S
    McGuffog, L
    Steele, D
    Devilee, P
    Klijn, JGM
    Meijers-Heijboer, H
    Radice, P
    Pilotti, S
    Nevanlinna, H
    Butzow, R
    Sobol, H
    Jacquemier, J
    Lyonet, DS
    Neuhausen, SL
    Weber, B
    Wagner, T
    Winqvist, R
    Bignon, YJ
    Monti, F
    Schmitt, F
    Lenoir, G
    Seitz, S
    Hamman, U
    Pharoah, P
    Lane, G
    Ponder, B
    Bishop, DT
    Easton, DF
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2473 - 2481
  • [46] Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients
    Aydemir, AEM
    Luleci, G
    Ozcelik, T
    Colak, T
    Schayek, H
    Akaydin, M
    Friedman, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 387 - 387
  • [47] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [48] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    M J L Ligtenberg
    F B L Hogervorst
    H W Willems
    P J W Arts
    G Brink
    S Hageman
    E A J Bosgoed
    E Van der Looij
    M A Rookus
    P Devilee
    E M A W Vos
    G Wigbout
    P M Struycken
    F H Menko
    E J Th Rutgers
    E H Hoefsloot
    E C M Mariman
    H G Brunner
    L J Van’t Veer
    British Journal of Cancer, 1999, 79 : 1475 - 1478
  • [49] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    Ligtenberg, MJL
    Hogervorst, FBL
    Willems, HW
    Arts, PJW
    Brink, G
    Hageman, S
    Bosgoed, EAJ
    Van der Looij, E
    Rookus, MA
    Devilee, P
    Vos, EMAW
    Wigbout, G
    Struycken, PM
    Menko, FH
    Rutgers, EJT
    Hoefsloot, EH
    Mariman, ECM
    Brunner, HG
    Van't Veer, LJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1475 - 1478
  • [50] Cancer treatment according to BRCA1 and BRCA2 mutations
    Kara N. Maxwell
    Susan M. Domchek
    Nature Reviews Clinical Oncology, 2012, 9 : 520 - 528
12345